Phase
Alumni community member
Umansense
UmanSense develops Stroke Alarm, a pioneering technology for early detection of stroke, consisting of two wristbands with sensors for wireless communication. With its AI-based software, the product detects if the user is having a stroke and then sends an alarm so that help can be provided quickly.
CEO Cecilia Wassélius Belfrage, who has a master in Business Administration and a master in Mechanical Engineering, founded the company with Dr. Johan Wassélius , MD, PhD, and inventor of the Stroke Alarm.
Did you know?
Today 75% of the stroke patients arrive too late for treatment and we want to change that.
Non-invasive cardiac pressure monitoring device
Accelerated drug development in oncology
Unique stem cell therapeutics
3D cell culture systems
Rapid Diagnostics for Multi-pathogen detection
Individualised information of the intestinal flora
Imaging solutions for life sciences
Novel probiotics for therapeutic effect
Treatments based on nature’s own defenses
Pest control solutions for bed bugs
Neonatal Lung Analyzer
Prebiotics for irritable bowel syndrome
Nanotechnology based infection control
Excellence in designing & executing drug discovery
Models for autoimmune & inflammatory conditions
Ultrasensitive cancer diagnostics & monitoring
Structural biology & drug discovery services
Male-Factor Infertility Diagnostics
Customized in vitro and in vivo services
Stroke detection device
Wound treatment gel
Regenerative medicine & cancer
